001230 5 02103523103201415 00021319A ID: 938806
Download Pdf The PPT/PDF document "72 Cancer Control Measures Promotion of ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
72 Cancer Control Measures Promotion of cancer researchPromotion of cancer preventionSubstantial decrease in the prevalence/death rate of cancer Goal of the strategy: Substantially decrease the prevalence and death rate of cancer, which is a major cause of death in Japan, through comprehensive promotion of research, prevention, and treatment. (1) Rapid promotion of research to elucidate the nature of cancer with cross-scientifical ideas and through introducing the latest science and technology. (2) Promotion of translational research for active utilization of basic research results in prevention, diagnosis, and treatment(3) Development of innovative prevention methods (4) Development of innovative diagnostic/treatment methods (5) Identification of the actual situation with cancer and distribution and dissemination of can
cer information/treatment technologies (1) Establishment of effective cancer prevention methods (2) Promotion of knowledge dissemination on cancer prevention (3) Improved preventive measures against cancer caused by infectious diseases (4) Early discovery/treatment of cancer (1) Improved cancer research/treatment functions of core facilities (2) ÒEeualizationÓ of cancer medical services(3) Improved quality of life (QOL) for cancer patients !,'-./0/-*012!,3'$-0&!!!!!"#$%&'(%!)*+),- !)&+$- !.+!)&+$-&##.+(!)*+),- !$&!0-&2&$.+(!10,).*#.=,35!2'#$.3.1).0#.+*-!*+3!)&20-,%,+1.4,!)*+),-!-,1,*-)%5 !*00-&0-.*$,!$-,*$2,+$!;*1,3!&+!1).,+$.9.)!A+&:#,3(,!-,(*-3#,11!&9!$%,!-,(.&+!.+!:%.)%!$%,!-,1.3,7!!@1$*;#.1%!*!1!$%*$!0-&4.3,1!2,3.)*# !&%62!!!8+!*33.$.&+!$&!)&+1'#$.+(!$%,!3.-,)$&-1!&9!$%,!-,#,4*+$!*32.+.1$-*$.4,!&-(*+.=*$.&+1!$%,!
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x Tj ;T Q;&#x q 0;&#x.936;é&#x 0 0;&#x 0.9;ãT 5;.8 ;ƒ ;m B;&#xT 8.;å 0;&#x 0 8;&#x.504; ;͓.;é¦&#x
276;&#x.365; Tm;&#x /F8;&#x.1 1;&#x Tf ;)&##,)$0-&4.3,!.+9&-2*$.&+!&+!)*+),-!2,3.)*#!)*-,7!!!82!,'-=-%/-*!-;!6#*6&'!'&0&#'6"!!!820#,2,+$!-,I'.-,3!2,*1'-,1!9&-!0-&2&$.+(!)*+),-!-,1,*-)%!*+3!.20-&4.+(!$%,!,+4.-&+2,+$!9&-!$%,!,*-#!*00-&4*#!&9!&#x Tj ;T Q;&#x q 0;&#x.936;é&#x 0 0;&#x 0.9;ãT 5;.8 ;ƒ ;m B;&#xT 8.;å 0;&#x 0 8;&#x.504; ;Б.;ã&#x 236;&#x.678; Tm;&#x /F8;&#x.1 1;&#x Tf ;3-'(12,3.)*#!3,4.),1!$%*$!*-,!%.(%#!+,,3,3!.+!)*+),-!$-,*$2,+$7 !*!G*+),-!G&+$-&#!B-&2&$.&+!G&'+).# !&9!D,*#$%5!E*;&'-!*+3!F,#9*-,5!:.$%!$%,!+'2;,-!&9!2,2;,-1!+&$!,?),,3.+(!KL7!!"#$%&'!D!!E#%&!-;!F*;-'6&=&*%!!!J%,!3*$,!&9!,+9&-),2,+$!&9!$%.1!#*:!1%*##!;,!"0-.#!M5!KLLN7!!!F.$%!-,(*-3!$&!$%,!,1$*;#.1%2,+$!&9!$%,!G*+),-!G&+$-&#!B-&2&$.&+!G&'+).#5 75 ! Promote measures in a comprehensive and systemat
ic manner while understanding and evaluating from the viewpoints of both quality and quantity the progress of individual goals of the ÒCancer Control ActÓ enforced in April 2007 and the ÒBasic Plan to Promote Cancer Control ProgramsÓ formulated in June 2007.(1) Training of staffs specialized in cancer medical care, including cancer specialists, etc. ¥ Training of staff specialized in cancer medical care ¥ Establishment of a system for training specialized doctors (2) Enhanced functions of core hospitals for collaborative cancer treatment ¥ Raised unit price of subsidies for core hospitals (increased number of cancer registration practitioners) (3) Promotion of joint international clinical trials and early approval of new drugs, etc. (1) Promotion of cancer prevention/early discovery Incidence rateLifetime riskPatients